PPARGC1A and metabolic dysfunction-associated steatotic liver disease: In the training set, compared with the control group, the NAFLD group showed significantly downregulated expression of ERN1, MYC, PPARGC1A, and SLC11A1, whereas TLR7 expression was significantly upregulated (Figure 5C).